Studie
- Sunitinib is superior to interferon α with respect to quality of life for patients with renal cell carcinoma
- Sunitinib in Patients With Metastatic Renal Cell Carcinoma
- Sunitinib Therapy for Patients with Metastatic Renal Cell Carcinoma: Updated Results of Two Phase II Trials and Prognostic Factor Analysis for Survival